Study of Biological Effects by Pulsed Bremsstrahlung Radiation of Ultrahigh Dose Rate at the Angara-5-1 Facility


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Radiological methods of treatment of malignant tumors are widespread in medical practice. In addition to the type of radiation and dose and fractionation of the radiation regime, the dose rate is one of the factors that affects the effectiveness of treatment. The therapeutic dose rate lies in the range of tens of mGy/s. At modern high-current accelerators of relativistic electron beams, a significant increase in the dose rate to hundreds of MGy/s is achievable, which is more than 108 times greater than the therapeutic dose rate. It is difficult to predict the nature of processes in tissues and its cells at such radiation intensities. To determine the effect of extreme dose rate on the radiosensitivity of tissues at the Angara-5-1 facility, experiments were conducted to determine the lethal dose (LD50/30) for laboratory mice. Our result on the study of the LD50/30 dose (~100 MGy/s) allows us to make a conclusion about a possible higher lethal dose than the power range of the doses used for medical purposes.

Sobre autores

V. Smirnov

Joint Institute for High Temperatures, Russian Academy of Sciences

Email: oleinik@triniti.ru
Rússia, Moscow, 125412

V. Bozhenko

Russian Scientific Center of Roentgenoradiology

Email: oleinik@triniti.ru
Rússia, Moscow, 117997

T. Gimadova

State Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: oleinik@triniti.ru
Rússia, Moscow, 123098

E. Grabovski

Troitsk Institute for Innovation and Fusion Research

Email: oleinik@triniti.ru
Rússia, Moscow, 142190

A. Gritsuk

Troitsk Institute for Innovation and Fusion Research

Email: oleinik@triniti.ru
Rússia, Moscow, 142190

A. Ivanov

Russian Scientific Center of Roentgenoradiology

Email: oleinik@triniti.ru
Rússia, Moscow, 117997

G. Oleinik

Troitsk Institute for Innovation and Fusion Research

Autor responsável pela correspondência
Email: oleinik@triniti.ru
Rússia, Moscow, 142190

E. Khmelevskii

Hertsen Moscow Oncology Research Center, Branch of FSBI NMRRC of the Ministry of Health of Russia

Email: oleinik@triniti.ru
Rússia, Moscow, 125284

A. Tsov’yanov

State Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: oleinik@triniti.ru
Rússia, Moscow, 123098

A. Shishkin

Russian Scientific Center of Roentgenoradiology

Email: oleinik@triniti.ru
Rússia, Moscow, 117997

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Ltd., 2018